How Do Drug Regulatory Bodies Deal With Potential Innovative Therapies?
Crossref DOI link: https://doi.org/10.1007/s43441-019-00045-x
Published Online: 2020-01-06
Published Print: 2020-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tutone, Michaela
Villa, Federico http://orcid.org/0000-0001-9772-5734
Addis, Antonio
Trotta, Francesco
Tafuri, Giovanni
Text and Data Mining valid from 2020-01-01
Article History
Received: 31 August 2018
Accepted: 26 November 2018
First Online: 6 January 2020